tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

West Pharmaceutical Services Inc

WST
Add to Watchlist
357.000USD
+1.520+0.43%
Close 07-23 16:00（ET）Quotes delayed by 15 min
25.31BMarket Cap
47.49P/E TTM

West Pharmaceutical Services Inc

357.000
+1.520+0.43%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

WST Financials

See West Pharmaceutical Services Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

West Pharmaceutical Services Inc Earnings Date

Latest Release
Jul 23, 2026
EPS / Forecast
2.18/2.08
Revenue / Forecast
872.30M/838.59M
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
3.07B
6.25%
EPS(YoY)
6.83
1.17%
Analyst Rating
BUY
2026/07/23
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
19.15%2.18
55.64%1.93
2.10%1.83
3.80%1.94
19.73%1.83
-21.04%1.24
-3.34%1.79
-13.95%1.87
-26.96%1.52
-16.52%1.57
33.73%1.85
--2.17
--2.09
--1.88
--1.38
--6.49
----
----
----
----
Revenue
13.80%872.30M
21.05%844.90M
7.51%805.00M
7.73%804.60M
9.17%766.50M
0.37%698.00M
2.30%748.80M
-0.07%746.90M
-6.86%702.10M
-2.96%695.40M
3.29%732.00M
8.81%747.40M
-2.27%753.80M
-0.47%716.60M
-3.02%708.70M
-2.77%686.90M
6.59%771.30M
7.35%720.00M
25.96%730.80M
28.92%706.50M
Net Profit
16.84%154.00M
54.57%138.80M
1.54%132.10M
2.94%140.00M
18.42%131.80M
-22.12%89.80M
-5.04%130.10M
-15.69%136.00M
-28.24%111.30M
-17.64%115.30M
33.01%137.00M
33.75%161.30M
-17.72%155.10M
-19.45%140.00M
-30.26%103.00M
-31.32%120.60M
0.64%188.50M
14.95%173.80M
50.10%147.70M
113.37%175.60M
Net Margin
2.67%17.65%
27.69%16.43%
-5.55%16.41%
-4.44%17.40%
8.47%17.20%
-22.41%12.87%
-7.17%17.37%
-15.63%18.21%
-22.96%15.85%
-15.13%16.58%
31.98%18.72%
--21.58%
--20.58%
--19.54%
--14.18%
--22.02%
----
----
----
----
Gross Margin
5.61%37.74%
5.59%35.08%
3.32%37.75%
3.21%36.58%
9.08%35.73%
0.36%33.22%
-3.86%36.54%
-8.12%35.44%
-15.26%32.76%
-12.56%33.10%
2.76%38.01%
--38.57%
--38.66%
--37.86%
--36.98%
--40.13%
----
----
----
----
Debt to assets ratio
-5.18%4.98%
-11.62%5.05%
-13.72%4.87%
-9.45%5.07%
-12.40%5.25%
-0.15%5.72%
4.50%5.64%
1.38%5.60%
5.82%5.99%
2.33%5.72%
-6.50%5.40%
--5.52%
--5.66%
--5.59%
--5.78%
--6.31%
----
----
----
----
Income Statement
Revenue
13.80%872.30M
21.05%844.90M
7.51%805.00M
7.73%804.60M
9.17%766.50M
0.37%698.00M
2.30%748.80M
-0.07%746.90M
-6.86%702.10M
-2.96%695.40M
3.29%732.00M
8.81%747.40M
-2.27%753.80M
-0.47%716.60M
-3.02%708.70M
-2.77%686.90M
6.59%771.30M
7.35%720.00M
25.96%730.80M
28.92%706.50M
Operating profit
11.94%179.10M
41.80%182.50M
4.35%175.20M
7.26%175.80M
24.51%160.00M
3.29%128.70M
0.06%167.90M
-11.60%163.90M
-30.95%128.50M
-25.88%124.60M
8.05%167.80M
0.00%185.40M
-17.55%186.10M
-10.82%168.10M
-17.53%155.30M
1.15%185.40M
8.20%225.70M
5.43%188.50M
57.31%188.30M
73.58%183.30M
Net Profit
16.84%154.00M
54.57%138.80M
1.54%132.10M
2.94%140.00M
18.42%131.80M
-22.12%89.80M
-5.04%130.10M
-15.69%136.00M
-28.24%111.30M
-17.64%115.30M
33.01%137.00M
33.75%161.30M
-17.72%155.10M
-19.45%140.00M
-30.26%103.00M
-31.32%120.60M
0.64%188.50M
14.95%173.80M
50.10%147.70M
113.37%175.60M
Balance Sheet
Current assets
7.53%1.81B
25.34%1.83B
28.61%1.98B
17.59%1.82B
13.34%1.68B
-13.91%1.46B
-20.57%1.54B
-21.38%1.55B
-20.87%1.48B
-12.61%1.69B
0.88%1.94B
13.77%1.97B
5.82%1.87B
14.59%1.94B
10.19%1.92B
8.47%1.73B
19.91%1.77B
27.39%1.69B
26.81%1.74B
29.07%1.60B
Total current liabilities
5.94%640.50M
27.97%674.00M
18.99%654.90M
23.02%635.40M
-4.59%604.60M
-18.77%526.70M
-18.07%550.40M
-3.19%516.50M
23.87%633.70M
21.22%648.40M
29.44%671.80M
16.82%533.50M
-9.47%511.60M
-8.53%534.90M
-12.64%519.00M
-18.24%456.70M
19.57%565.10M
21.13%584.80M
18.02%594.10M
24.77%558.60M
Total assets
3.13%4.08B
13.59%4.11B
17.20%4.27B
11.72%4.11B
13.28%3.95B
0.44%3.62B
-4.86%3.64B
-2.12%3.68B
-4.91%3.49B
-3.26%3.60B
5.88%3.83B
13.20%3.75B
9.16%3.67B
13.02%3.72B
9.14%3.62B
5.54%3.32B
14.60%3.36B
20.26%3.29B
18.61%3.31B
21.67%3.14B
Total liabilities
6.11%1.09B
19.71%1.12B
13.83%1.09B
14.23%1.05B
12.17%1.02B
1.45%935.10M
1.33%961.10M
4.12%923.00M
-1.12%912.60M
-2.71%921.70M
1.78%948.50M
4.79%886.50M
-1.54%922.90M
-2.18%947.40M
-4.75%931.90M
-10.03%846.00M
4.04%937.30M
6.35%968.50M
4.16%978.40M
8.84%940.30M
Total equity
2.09%2.99B
11.45%2.99B
18.41%3.18B
10.88%3.05B
13.67%2.93B
0.09%2.68B
-6.90%2.68B
-4.05%2.75B
-6.19%2.58B
-3.44%2.68B
7.30%2.88B
16.08%2.87B
13.29%2.75B
19.34%2.78B
14.97%2.68B
12.19%2.47B
19.28%2.42B
27.18%2.33B
25.93%2.34B
28.12%2.20B
Cash Flow Statement
Net operating income
-29.98%124.00M
-30.53%89.90M
32.09%251.10M
9.49%197.20M
7.33%177.10M
9.48%129.40M
-20.49%190.10M
-21.73%180.10M
-2.48%165.00M
-14.41%118.20M
3.60%239.10M
36.23%230.10M
-2.25%169.20M
-8.66%138.10M
43.53%230.80M
-11.15%168.90M
19.88%173.10M
70.46%151.20M
8.14%160.80M
60.29%190.10M
Net investment
42.55%-43.20M
40.11%-42.70M
27.39%-76.10M
22.90%-63.30M
25.69%-75.20M
21.30%-71.30M
3.68%-104.80M
14.21%-82.10M
-23.26%-101.20M
-10.35%-90.60M
-14.77%-108.80M
-61.93%-95.70M
-24.39%-82.10M
-20.20%-82.10M
-22.48%-94.80M
9.49%-59.10M
-18.07%-66.00M
-25.32%-68.30M
-34.38%-77.40M
-32.99%-65.30M
Net financing
-1006.04%-164.80M
-110.00%-308.70M
83.02%-11.70M
82.14%-11.50M
93.17%-14.90M
45.76%-147.00M
63.64%-68.90M
-188.79%-64.40M
-23.47%-218.30M
-281.69%-271.00M
-1894.74%-189.50M
70.35%-22.30M
-388.40%-176.80M
58.89%-71.00M
-53.23%-9.50M
-1196.55%-75.20M
-12166.67%-36.20M
-10.42%-172.70M
28.74%-6.20M
19.44%-5.80M

FAQs

What is the total revenue of West Pharmaceutical Services Inc?

According to West Pharmaceutical Services Inc's FY2025 earnings report, its total revenue reached 3.07B, with a year-on-year change of 2.89B.

What are the current assets of West Pharmaceutical Services Inc?

According to West Pharmaceutical Services Inc's FY2025 earnings report, its current assets were 1.98B, with a year-on-year change of 28.61.

What are the total assets of West Pharmaceutical Services Inc?

According to West Pharmaceutical Services Inc's FY2025 earnings report, its total assets of West Pharmaceutical Services Inc were 4.27B, with a year-on-year change of 17.20.

What are the total liabilities of West Pharmaceutical Services Inc?

According to West Pharmaceutical Services Inc's FY2025 earnings report, its total liabilities of West Pharmaceutical Services Inc were 1.09B, with a year-on-year change of 13.83.

What is the total equity of West Pharmaceutical Services Inc?

According to West Pharmaceutical Services Inc's FY2025 earnings report, its total equity of West Pharmaceutical Services Inc was 3.18B, with a year-on-year change of 18.41.

What is the net operating income of West Pharmaceutical Services Inc?

According to West Pharmaceutical Services Inc's FY2025 earnings report, its net operating income of West Pharmaceutical Services Inc was 639.70M, with a year-on-year change of 7.58.

What is the net investment of West Pharmaceutical Services Inc?

According to West Pharmaceutical Services Inc's FY2025 earnings report, its net investment of West Pharmaceutical Services Inc was -285.90M, with a year-on-year change of 24.50.

What is the net financing of West Pharmaceutical Services Inc?

According to West Pharmaceutical Services Inc's FY2025 earnings report, its net financing of West Pharmaceutical Services Inc was -185.10M, with a year-on-year change of 70.27.

What is the Earnings Per Share (EPS) of West Pharmaceutical Services Inc?

According to West Pharmaceutical Services Inc's FY2025 earnings report, its Earnings Per Share (EPS) was 6.83, with a year-on-year change of 1.17.

What is the net income of West Pharmaceutical Services Inc?

According to West Pharmaceutical Services Inc's FY2025 earnings report, its net income was 493.70M, with a year-on-year change of 0.20.

What is the net margin of West Pharmaceutical Services Inc?

According to West Pharmaceutical Services Inc's FY2025 earnings report, its net profit margin was 16.06, with a year-on-year change of -5.69.

What is the gross margin of West Pharmaceutical Services Inc?

According to West Pharmaceutical Services Inc's FY2025 earnings report, its gross margin was 35.91, with a year-on-year change of 4.04.

What is the debt-to-asset ratio of West Pharmaceutical Services Inc?

According to West Pharmaceutical Services Inc's FY2025 earnings report, its debt-to-asset ratio was 4.87, with a year-on-year change of -13.72.

What is the Return on Equity (ROE) of West Pharmaceutical Services Inc?

According to West Pharmaceutical Services Inc's FY2025 earnings report, its Return on Equity (ROE) was 16.85, with a year-on-year change of -4.84.

What is the Return on Assets (ROA) of West Pharmaceutical Services Inc?

According to West Pharmaceutical Services Inc's FY2025 earnings report, its Return on Assets (ROA) was 12.48, with a year-on-year change of -5.37.

What is the operating profit of West Pharmaceutical Services Inc?

According to West Pharmaceutical Services Inc's FY2025 earnings report, its operating profit was 639.70M, with a year-on-year change of 7.58.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy